DEXYCU
Commercial- Indications
- Post-operative inflammation
Company intelligence / Profile preview
Sincerus Florida operates as an FDA-regulated outsourcing facility specializing in the manufacture and distribution of customized sterile and nonsterile pharmaceutical preparations. The company primarily serves dermatologists with point-of-care dispensing solutions that allow private labeling. It has experienced significant growth, recently securing major financing to expand its state-of-the-art manufacturing capabilities. Its business model enables physicians to offer tailored medications without third-party payor restrictions, focusing on improved compliance and cost savings for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sincerus Florida.